生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK4139 生物科技

交易中 02-09 14:31:08 EST

1,156.82

-6.33

-0.54%

最高1,163.32	最低1,150.91	成交量3.85亿
今开1,163.13	昨收1,163.14	日振幅1.07%
总市值0.00	流通市值0.00	总股本0.00
成交额79.94亿	换手率--	流通股本0.00
市净率7.222551	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"生物科技","latestPrice":1156.8163,"timestamp":1770665468832,"preClose":1163.1443,"halted":0,"volume":385259038,"delay":0,"changeRate":-0.00544,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-6.328003,"latestTime":"02-09 14:31:08 EST","open":1163.1263,"high":1163.3179,"low":1150.9094,"amount":7993783328.013544,"amplitude":0.010668,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770670800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":7.222551,"peRate":-161.424724,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK4139","defaultTab":"news","newsList":[{"id":"2610654302","title":"Bioaffinity Technologies, Inc.盘中异动 大幅上涨5.50%报0.898美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610654302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610654302?lang=zh_cn&edition=full","pubTime":"2026-02-09 23:02","pubTimestamp":1770649324,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日23时02分，Bioaffinity Technologies, Inc.股票出现波动，股价快速上涨5.50%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体跌幅为1.23%。其相关个股中，Genedx Holdings Corp.、Bioaffinity Technologies, Inc.、Natera, Inc.涨幅较大，Xwell, Inc.、Ispecimen Inc.、Inotiv, Inc.较为活跃，换手率分别为91.26%、8.68%、0.88%，振幅较大的相关个股有Xwell, Inc.、Inotiv, Inc.、Ispecimen Inc.，振幅分别为31.30%、17.33%、12.97%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209230204a48fafca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209230204a48fafca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2610265215","title":"Pepgen Inc.盘中异动 早盘急速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610265215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610265215?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:43","pubTimestamp":1770648225,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日22时43分，Pepgen Inc.股票出现波动，股价快速下跌5.13%。截至发稿，该股报4.25美元/股，成交量3.4237万股，换手率0.05%，振幅5.25%。Pepgen Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Pepgen Inc.公司简介：PepGen Inc 是一家临床阶段的生物技术公司，致力于推进下一代寡核苷酸治疗药物，以改变严重神经肌肉和神经系统疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020922434597a58285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020922434597a58285&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2610765919","title":"美股异动 | 礼来(LLY.US)涨逾3% 将收购免疫细胞工程公司Orna Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2610765919","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610765919?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:41","pubTimestamp":1770648112,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，礼来涨逾3%，报1095.87美元。消息面上，2月9日，Orna Therapeutics宣布与礼来达成最终收购协议，礼来将全面收购Orna，以强化其在细胞疗法与基因药物领域的布局。Orna股东最高可获得24亿美元现金，包括预付款及达成特定临床开发里程碑后的后续款项。根据协议，本次收购的核心标的是Orna的环状RNA技术平台及体内CAR-T管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403381.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BWXC8680.SGD","LU2746668974.SGD","IE00BK4W5M84.HKD","LU0882574139.USD","LU0823434583.USD","LU0234572021.USD","IE00B1XK9C88.USD","ELIS","LU0823434740.USD","LU2602419157.SGD","LU1069344957.HKD","LU1712237335.SGD","LU1917777945.USD","IWN","LU2211815571.USD","LU1035775433.USD","LU2471134523.USD","GB00BDT5M118.USD","LU2756315664.SGD","LU2491050154.USD","LU0432979614.USD","SG9999001176.USD","IE00BKPKM429.USD","LU0109394709.USD","LU1127390331.HKD","IE0004445015.USD","LU0114720955.EUR","TWM","LU1868836757.USD","LU2063271972.USD","BK4516","LU2265009873.SGD","LU1988902786.USD","IE00B1BXHZ80.USD","LU2237443549.SGD","LU0820561818.USD","LU2213496289.HKD","LU2456880835.USD","LU2468319806.SGD","LU2023250330.USD","LU0943347566.SGD","SG9999015945.SGD","IE00BJT1NW94.SGD","IWO","LU2237443895.HKD","LU2236285917.USD","SG9999014914.USD","LU2108987350.USD","LU0198837287.USD","LU0094547139.USD","LU0964807845.USD","LU1983299246.USD","LU2271345857.HKD","LU2491050071.SGD","IE00B7KXQ091.USD","LU1804176565.USD","LU0354030511.USD","LU1720051108.HKD","LU1145028129.USD","LU1814569148.SGD","SG9999015952.SGD","LU0238689110.USD","LU1974910355.USD","LLYX","LU0640476718.USD","IE00B775H168.HKD","IE00BFSS8Q28.SGD","LU0006306889.USD","LU0353189680.USD","LU1057294990.SGD","LU1720051017.SGD","ELIL","LU0203201768.USD","LU1093756168.USD","LU1366192091.USD","IE0002141913.USD","LU0158827781.USD","LU0417517546.SGD","LU1064131342.USD","LU0256863902.USD","LU0882574055.USD","LU0323591593.USD","LU0823416689.USD","LU0266013472.USD","LU2168564495.EUR","LU2237443622.USD","SG9999014898.SGD","LU2750360641.GBP","LU0158827948.USD","SGXZ57979304.SGD","LU0708995401.HKD","LU2357305700.SGD","LU0079474960.USD","MNQmain","LU2471134879.HKD","LLYZ","LU2756315318.SGD","LU1551013342.USD","LU2360106947.USD","LU2087625088.SGD","RWM","LU0354030438.USD","LU1267930730.SGD","BK4550","LU2461242641.AUD","IE00BK4W5L77.USD","IE00BN29S564.USD","LU1989771016.USD","IE00B2B36J28.USD","LU1291159041.SGD","LU0471298777.SGD","SG9999018865.SGD","LU2471134796.USD","IE00BJJMRY28.SGD","BK4585","LU2471134952.CNY","UWM","LU1868837136.USD","IE00B4JS1V06.HKD","LU0672654240.SGD","LU1551013425.SGD","LU0385154629.USD","SG9999017495.SGD","IE00BJJMRZ35.SGD","BK4533","LU2552382132.HKD","BK4534","LU2111349929.HKD","SG9999013999.USD","LU1629891620.HKD","LU2264538146.SGD","LU0689472784.USD","LU2168564065.EUR","BK4139","LU0225283273.USD","LU0210536198.USD","LU0316494557.USD","LU0106261372.USD","LU0787776722.HKD","LU0889565916.HKD","LU2028103732.USD","SGXZ51526630.SGD","LU0820561909.HKD","LU0122379950.USD","LU0786609619.USD","LU2023251221.USD","LU2168564222.USD","LU0683600562.USD","LU1623119135.USD","SGXZ81514606.USD","LU0320765059.SGD","LU2237443978.SGD","LU2491049909.HKD","LU0058720904.USD","IE00BJJMRX11.SGD","LU0820562030.AUD","LU2168564149.EUR","LU2089283258.USD","LU1868836914.USD","LU2023250504.SGD","LU0353189763.USD","LU1868837300.USD","LU2237443465.HKD","LU2361044949.HKD","LU0109391861.USD","BK4588","LU1323610961.USD","LU2417539215.USD","IE0004445239.USD","LU0061475181.USD","LU0097036916.USD","LU0320765992.SGD","LU1093756325.SGD","LU2324357040.USD","LU0466842654.USD","SG9999014906.USD","LU2896262040.SGD","SG9999014880.SGD","IE00B4R5TH58.HKD","SG9999018857.SGD","LU0289739699.SGD","LU1061106388.HKD","LU0471298694.HKD","LU2112291526.USD","LU0456855351.SGD","BK4599","LU2746668461.USD","LU0256863811.USD","LU1868836591.USD","BK4581","LU2089984988.USD","SG9999015986.USD","SGXZ31699556.SGD","SRTY","TNA","LU0203202063.USD","IE0009355771.USD","LU0096364046.USD","LLY","LU2462157665.USD","LU2361044865.SGD","LU2361045086.USD","IE00BFTCPJ56.SGD","IE0005OL40V9.USD","LU1548497426.USD","SG9999001176.SGD","LU2750360997.AUD","SGXZ99366536.SGD","IE00BFSS7M15.SGD","LU2552382215.SGD","LU1232071149.USD","SG9999015978.USD","LU2552382058.USD","TZA","IE00BKDWB100.SGD","LU1023059063.AUD","LU2106854487.HKD","BK4535","LU2089284900.SGD","LU2237443382.USD","LU2237438978.USD","LU2168563687.JPY","BK4539","IE00BJLML261.HKD","LU1280957306.USD","BK4007"],"gpt_icon":0},{"id":"2610937668","title":"艾切托盘中异动 股价大涨16.50%报8.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610937668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610937668?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:33","pubTimestamp":1770647588,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日22时33分，艾切托股票出现异动，股价急速上涨16.50%。截至发稿，该股报8.19美元/股，成交量3.445万股，换手率0.36%，振幅18.35%。艾切托股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，艾切托、Novabay Pharmaceuticals, Inc.、Anavex Life Sciences Corp.涨幅较大，Agomab Therapeutics Nv、Liminatus Pharma, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为57.29%、26.62%、19.80%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Genenta Science Spa、艾切托，振幅分别为34.95%、28.39%、18.35%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209223308a48f9b40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209223308a48f9b40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2610651856","title":"Onconetix, Inc.盘中异动 早盘快速拉升5.98%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610651856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610651856?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:32","pubTimestamp":1770647558,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日22时32分，Onconetix, Inc.股票出现波动，股价大幅拉升5.98%。截至发稿，该股报1.24美元/股，成交量614股，换手率0.04%，振幅0.81%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209223238a6e68e16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209223238a6e68e16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"1171837745","title":"Lunai Bioworks (纳斯达克: LNAI) 携手临床阶段合作伙伴启动AI肿瘤学试点项目，分析转移性结直肠癌生存期随机II期试验数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1171837745","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171837745?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:18","pubTimestamp":1770646723,"startTime":"0","endTime":"0","summary":"Lunai Bioworks (纳斯达克: LNAI) 近日宣布，与一家临床阶段的合作伙伴共同启动了一项人工智能肿瘤学试点项目。该项目的核心任务是利用先进的人工智能技术，对一项针对转移性结直肠癌患者的随机II期生存期临床试验数据进行深度分析。此举旨在探索AI在加速肿瘤学研究与药物开发方面的巨大潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"gpt_icon":0},{"id":"2610990656","title":"百济神州：公司会在定期报告中面向所有投资者统一披露截至相应报告期末的股东户数","url":"https://stock-news.laohu8.com/highlight/detail?id=2610990656","media":"证券日报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610990656?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:05","pubTimestamp":1770645946,"startTime":"0","endTime":"0","summary":"证券日报网讯2月9日，百济神州在互动平台回答投资者提问时表示，公司在已披露的2025年第三季度报告中公布，截至2025年9月30日，公司普通股的登记股东有36164户（其中包括人民币股份登记股东36008户，41户登记在港股股东名册及115户登记在瑞士股东名册的股东）和8户美国存托股份的记录持有人，合计36172户。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602093645740228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1500","LU0588546209.SGD","BK1588","BK4585","LU1251922891.USD","LU1969619763.USD","BK4526","688235","BK4139","06160","BK1161","LU0307460666.USD","LU1303224171.USD","LU2328871848.SGD","LU1719994722.HKD","BK0239","LU1770034418.SGD","BK1583","ONC"],"gpt_icon":0},{"id":"1150702372","title":"TriSalus生命科学任命资深医疗投资者Michael Stansky加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1150702372","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150702372?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:04","pubTimestamp":1770645861,"startTime":"0","endTime":"0","summary":"TriSalus生命科学公司（TriSalus Life Sciences Inc.）宣布，资深医疗投资专家Michael Stansky已正式加入其董事会。这一任命标志着公司进一步加强治理结构，并借助Stansky先生在医疗投资领域的丰富经验推动战略发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSI","BK4139"],"gpt_icon":0},{"id":"1151781838","title":"Solid Biosciences就SGT-003基因疗法治疗杜氏肌营养不良症与FDA达成C类会议积极共识","url":"https://stock-news.laohu8.com/highlight/detail?id=1151781838","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151781838?lang=zh_cn&edition=full","pubTime":"2026-02-09 21:05","pubTimestamp":1770642307,"startTime":"0","endTime":"0","summary":"Solid Biosciences（纳斯达克代码：SLDB）近日宣布，其针对杜氏肌营养不良症（DMD）研发的SGT-003基因疗法，在与美国食品药品监督管理局（FDA）举行的C类会议中获得了积极反馈。这一关键进展为该项目后续的临床开发计划清除了重要监管障碍。\nFDA对SGT-003现有的临床前数据包表示了认可，并就下一阶段的临床试验设计提供了建设性指导。此次积极的监管互动标志着SGT-003项目向前迈出了实质性的一步，增强了其治疗DMD这一严重遗传性疾病的潜力。公司计划基于此次会议反馈，加快推进SGT-003的临床开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLDB","BK4139"],"gpt_icon":0},{"id":"1138765222","title":"Anixa Biosciences卵巢癌CAR-T疗法试验获积极患者生存数据，监管批准实现重大剂量递增","url":"https://stock-news.laohu8.com/highlight/detail?id=1138765222","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138765222?lang=zh_cn&edition=full","pubTime":"2026-02-09 21:03","pubTimestamp":1770642237,"startTime":"0","endTime":"0","summary":"Anixa Biosciences宣布，其针对卵巢癌的CAR-T细胞疗法临床试验取得鼓舞人心的患者生存观察结果。公司同时获得监管机构批准，得以实施重大剂量递增方案，为后续疗效评估提供关键支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANIX"],"gpt_icon":0},{"id":"1100033579","title":"Krystal Biotech宣布FDA授予KB707再生医学先进疗法认定，用于治疗晚期或转移性非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1100033579","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100033579?lang=zh_cn&edition=full","pubTime":"2026-02-09 21:03","pubTimestamp":1770642196,"startTime":"0","endTime":"0","summary":"Krystal Biotech Inc.宣布，其候选疗法KB707已获得美国食品药品监督管理局（FDA）授予的再生医学先进疗法（RMAT）认定，适应症为晚期或转移性非小细胞肺癌（NSCLC）。\nRMAT认定旨在加速针对严重或危及生命疾病的新型再生医学产品的开发和审评。此次认定基于KB707在临床前研究中展现出的潜力，该疗法是一种基于基因工程的创新疗法。\n获得RMAT资格意味着KB707有资格获得FDA的强化指导，并可能获得优先审评和加速批准等便利。这对于推进该疗法的临床开发进程具有重要意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"1139246758","title":"Anavex Life Sciences Corp：预计按当前现金消耗率 现金跑道可维持逾三年","url":"https://stock-news.laohu8.com/highlight/detail?id=1139246758","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139246758?lang=zh_cn&edition=full","pubTime":"2026-02-09 20:35","pubTimestamp":1770640510,"startTime":"0","endTime":"0","summary":"Anavex Life Sciences Corp（简称Anavex Life Sciences）近日透露，依照公司当前的现金消耗速度测算，其现有资金储备预计可支撑运营超过三年。这一数据为生物制药企业的持续研发提供了稳定的财务保障，展现出公司在资金管理方面的稳健态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"1195685429","title":"Anavex Life Sciences公布2026财年第一季度财务业绩并更新业务进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1195685429","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195685429?lang=zh_cn&edition=full","pubTime":"2026-02-09 20:31","pubTimestamp":1770640277,"startTime":"0","endTime":"0","summary":"Anavex Life Sciences Corp. (AVXL) 近日披露了其2026财年第一季度的财务报告，同时向市场同步了公司最新的业务动态。此次披露涵盖了公司在报告期内的财务状况及研发管线的重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2610375196","title":"礼来(LLY.US)将斥资不超过24亿美元现金收购生物技术公司Orna Therapeutics。","url":"https://stock-news.laohu8.com/highlight/detail?id=2610375196","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610375196?lang=zh_cn&edition=full","pubTime":"2026-02-09 20:03","pubTimestamp":1770638609,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0683600562.USD","IE00BJJMRX11.SGD","LU0238689110.USD","LU1069344957.HKD","LU2089984988.USD","LU1093756325.SGD","LU0203201768.USD","LU0882574139.USD","SG9999018865.SGD","LU0353189680.USD","LU1280957306.USD","LU0471298777.SGD","LU0882574055.USD","LU2491049909.HKD","IE00B1XK9C88.USD","LU0058720904.USD","LU2461242641.AUD","LU0823434740.USD","LU2264538146.SGD","GB00BDT5M118.USD","LU2750360997.AUD","IE00B4JS1V06.HKD","LU1868836757.USD","LU2237443549.SGD","LU2087625088.SGD","LU2471134952.CNY","LU0320765059.SGD","IE00BFSS8Q28.SGD","BK4516","LU0316494557.USD","SG9999017495.SGD","LU0094547139.USD","LU2211815571.USD","ELIS","LU0061475181.USD","LU0158827781.USD","LU0466842654.USD","LU2237443622.USD","SG9999015952.SGD","LU0820561818.USD","LLY","SG9999015986.USD","LU1061106388.HKD","LU2237443978.SGD","LU1145028129.USD","LU2265009873.SGD","LU2468319806.SGD","LU2471134796.USD","LU0786609619.USD","LU0109394709.USD","LLYX","LU0385154629.USD","LU0158827948.USD","LU2236285917.USD","LU0354030438.USD","IE00BWXC8680.SGD","IE0005OL40V9.USD","LU2602419157.SGD","BK4585","LU2023250330.USD","IE00BJJMRY28.SGD","LU2023251221.USD","LU2491050154.USD","LU2361045086.USD","LU0097036916.USD","LU0006306889.USD","LU2111349929.HKD","LU2756315318.SGD","LU1323610961.USD","SG9999018857.SGD","BK4007","IE00B4R5TH58.HKD","LU2456880835.USD","LU1551013342.USD","LU2746668974.SGD","LU0114720955.EUR","LU2063271972.USD","LU0109391861.USD","LU1551013425.SGD","LU1623119135.USD","LU2746668461.USD","SG9999014914.USD","LU0354030511.USD","LU1974910355.USD","SGXZ31699556.SGD","LU0096364046.USD","LU2471134879.HKD","LU1868837300.USD","IE00BK4W5L77.USD","LU0256863902.USD","LU1127390331.HKD","LU1366192091.USD","BK4539","LU1868836914.USD","SG9999015945.SGD","LU2756315664.SGD","LU2106854487.HKD","LU2089283258.USD","IE00BFSS7M15.SGD","LU0823434583.USD","LU1548497426.USD","LU2237438978.USD","IE00B7KXQ091.USD","LU0106261372.USD","SGXZ51526630.SGD","LU2750360641.GBP","LU0471298694.HKD","LU2491050071.SGD","LU1629891620.HKD","LLYZ","LU0323591593.USD","IE0004445015.USD","LU2462157665.USD","LU1720051017.SGD","SG9999015978.USD","LU0943347566.SGD","LU0198837287.USD","LU0820562030.AUD","LU2237443895.HKD","LU1035775433.USD","SG9999013999.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU2324357040.USD","SGXZ99366536.SGD","BK4588","LU0417517546.SGD","IE0002141913.USD","LU1804176565.USD","SG9999014880.SGD","LU1023059063.AUD","LU1983299246.USD","LU2896262040.SGD","IE0009355771.USD","LU1064131342.USD","LU2112291526.USD","LU0079474960.USD","SGXZ81514606.USD","LU0122379950.USD","IE00BKDWB100.SGD","SG9999014898.SGD","LU0432979614.USD","LU0210536198.USD","LU0820561909.HKD","LU0203202063.USD","LU0672654240.SGD","LU2028103732.USD","LU0353189763.USD","LU2089284900.SGD","BK4533","LU2237443465.HKD","LU2237443382.USD","LU2108987350.USD","LU0787776722.HKD","LU0289739699.SGD","LU1291159041.SGD","BK4599","LU0234572021.USD","LU2417539215.USD","LU2023250504.SGD","LU2213496289.HKD","LU0256863811.USD","LU1720051108.HKD","LU0708995401.HKD","LU0640476718.USD","SG9999014906.USD","LU2168564222.USD","BK4139","LU2168564065.EUR","LU0964807845.USD","LU1232071149.USD","LU1988902786.USD","IE0004445239.USD","IE00BK4W5M84.HKD","ELIL","LU0823416689.USD","LU2552382215.SGD","LU2168563687.JPY","LU1093756168.USD","LU2552382058.USD","LU0689472784.USD","LU2471134523.USD","LU0456855351.SGD","IE00B1BXHZ80.USD","IE00BKPKM429.USD","LU1267930730.SGD","LU1868837136.USD","LU2357305700.SGD","LU0266013472.USD","LU2361044865.SGD","LU2552382132.HKD","LU1917777945.USD","IE00BJLML261.HKD","LU1989771016.USD","LU1868836591.USD","LU1712237335.SGD","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU2168564149.EUR","LU2360106947.USD","SGXZ57979304.SGD","SG9999001176.USD","BK4581","IE00BJT1NW94.SGD","LU2271345857.HKD","BK4534","LU1814569148.SGD","LU2168564495.EUR","LU2361044949.HKD","IE00B775H168.HKD","LU0320765992.SGD","IE00BN29S564.USD","LU0225283273.USD","SG9999001176.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"1195472595","title":"曼恩凯德生物医疗宣布首例患者加入Inhale-1St儿科研究，评估Afrezza®用于新诊断1型糖尿病青少年","url":"https://stock-news.laohu8.com/highlight/detail?id=1195472595","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195472595?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:10","pubTimestamp":1770635403,"startTime":"0","endTime":"0","summary":"曼恩凯德生物医疗宣布，其Inhale-1St儿科研究项目已完成首例患者入组。该研究旨在评估吸入式胰岛素产品Afrezza®在新确诊1型糖尿病青少年群体中的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","BK4139","MNKD"],"gpt_icon":0},{"id":"2610684644","title":"Argus上调安进目标价至400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610684644","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610684644?lang=zh_cn&edition=full","pubTime":"2026-02-09 15:22","pubTimestamp":1770621743,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1057294990.SGD","LU1571399168.USD","LU0289739699.SGD","LU1023059063.AUD","LU1983299246.USD","BK4588","BK4566","LU2242646821.SGD","AMGN","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU2242652126.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4139","BK4585","LU2468319806.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","LU0320765992.SGD","BK4581","LU0868494617.USD","BK4599","LU0122379950.USD","LU0058720904.USD","LU0889565916.HKD","IE0002141913.USD","BK4534","LU2112291526.USD","BK4533","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2610681706","title":"中疾控发布2026年2月春节假期期间健康防护提示","url":"https://stock-news.laohu8.com/highlight/detail?id=2610681706","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610681706?lang=zh_cn&edition=full","pubTime":"2026-02-09 15:02","pubTimestamp":1770620520,"startTime":"0","endTime":"0","summary":"中国疾病预防控制中心温馨提示：2月份春节假期期间，需做好防寒保暖，需关注流行性感冒等其他急性呼吸道传染病、人感染禽流感、诺如病毒胃肠炎、食源性疾病和一氧化碳中毒等；出境旅行需关注目的地登革热、基孔肯雅热、寨卡病毒病等蚊媒传染病以及尼帕病毒病等疫情风险。春节假期前往热带和亚热带地区旅行，应注意做好防蚊虫叮咬措施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-02-09/doc-inhmfcph5410129.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-02-09/doc-inhmfcph5410129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ARDS","BK4139"],"gpt_icon":0},{"id":"2610568695","title":"高盛：今年内地医疗板块更依赖数据及盈利能见度 看好CDMO企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2610568695","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610568695?lang=zh_cn&edition=full","pubTime":"2026-02-09 14:08","pubTimestamp":1770617323,"startTime":"0","endTime":"0","summary":"今年要获得超越行业的回报，更依赖于关键数据公布、实际成交，以及盈利兑现或转折点的能见度。该行对医疗器械板块维持中性看法，虽然行业已触底，但需时逐步复苏；推荐买时代天使及威高股份。医疗服务板块方面，该行仍持相对谨慎态度，因成本控制措施的持续影响，以及疲弱的消费周期；下调海吉亚医疗评级至“中性”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","LU0708995583.HKD","BK4139","LU2488822045.USD","LU0052750758.USD","LU0320764599.SGD","06990","LU1046422090.SGD","LU2045819591.USD","HK0000306701.USD","03692","HK0000320264.USD","LU2125910500.SGD","BK1161","02268","BK1589","02359","LU2242644610.SGD","159891","LU0196878994.USD","CDMO","BK1191","HK0000306685.HKD","HK0000320223.HKD","HK0000165453.HKD","SG9999014674.SGD","BK1576","BK1141","02696"],"gpt_icon":0},{"id":"1111244728","title":"TG Therapeutics携手克里斯蒂娜·艾伯盖特推动多发性硬化症疾病认知普及","url":"https://stock-news.laohu8.com/highlight/detail?id=1111244728","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111244728?lang=zh_cn&edition=full","pubTime":"2026-02-09 05:18","pubTimestamp":1770585490,"startTime":"0","endTime":"0","summary":"生物制药公司TG Therapeutics近日宣布，将与知名演员克里斯蒂娜·艾伯盖特展开深度合作，共同致力于提升公众对多发性硬化症的认知水平。此次合作旨在通过名人影响力扩大疾病科普覆盖面，帮助患者群体获得更广泛的社会支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4588","TGTX"],"gpt_icon":0},{"id":"2610632735","title":"海外科技行业周报：美伊第一轮谈判结束 风偏重启但风险犹存","url":"https://stock-news.laohu8.com/highlight/detail?id=2610632735","media":"华源证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610632735?lang=zh_cn&edition=full","pubTime":"2026-02-09 00:00","pubTimestamp":1770566400,"startTime":"0","endTime":"0","summary":"海外AI 能源：本周Bloom Energy 发布2025 年四季度财报，业绩超预期。CORPAY 以12.6%的涨幅领涨。Visa Direct 与UnionPay International 将全球资金转移网络扩展至中国大陆数十亿张银行卡。我们认为，全球支付行业正在发生一轮清晰的“层级分化”。美伊第一轮谈判后，市场风偏快速重启，领涨的依然是我们认可的泛AI、商业航天等方向。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209194151a6e6023a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209194151a6e6023a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PYPL","LU1861220207.SGD","BK4527","BK4023","BK4533","LU0158827948.USD","PYPY","LU1668664300.SGD","BK4106","LU1791807156.HKD","LU2360107671.USD","LU1861217088.USD","BK4524","BK4554","BK4585","BK4598","BK4581","BK4528","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","LU2089284900.SGD","BK4543","BK4535","BE","BK4587","PYPG","BK4534","LU2023251221.USD","LU2089283258.USD","IE00BQXX3C00.GBP","BK4551","BK4227","CPAY","BK4139","BK4588","LU0106831901.USD","BK4566","AI"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"name":"生物科技","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,BK4139,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}